Literature DB >> 15746088

Clinical significance of intrahepatic hepatitis B virus covalently closed circular DNA in chronic hepatitis B patients who received cytotoxic chemotherapy.

Chee-Kin Hui, Scott Bowden, Kathy Jackson, Wing-yan Au, Daniel Y T Fong, Albert K W Lie, Chor-sang Chim, Raymond Liang, George K K Lau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15746088     DOI： 10.1182/blood-2004-09-3402

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy.

Authors:  C-K Hui; W W W Cheung; W-Y Au; A K W Lie; H-Y Zhang; Y-H Yueng; B C Y Wong; N Leung; Y-L Kwong; R Liang; G K K Lau
Journal:  Gut       Date:  2005-07-06       Impact factor: 23.059

2.  Management of hepatitis B virus-related acute liver failure.

Authors:  Makoto Oketani; Hirofumi Uto; Akio Ido; Hirohito Tsubouchi
Journal:  Clin J Gastroenterol       Date:  2014-01-24

3.  Hepatitis B reactivation after chemotherapy: two decades of clinical research.

Authors:  George K K Lau
Journal:  Hepatol Int       Date:  2008-03-05       Impact factor: 6.047

4.  New developments in HBV molecular diagnostics and quantitative serology.

Authors:  D Scott Bowden; Alex J Thompson
Journal:  Hepatol Int       Date:  2008-02-13       Impact factor: 6.047

5.  DNA Repair Factor Poly(ADP-Ribose) Polymerase 1 Is a Proviral Factor in Hepatitis B Virus Covalently Closed Circular DNA Formation.

Authors:  Yingshan Chen; Yongxuan Yao; Kaitao Zhao; Canyu Liu; Yifei Yuan; Hao Sun; Dan Huang; Yi Zheng; Yuan Zhou; Jizheng Chen; Yun Wang; Chunchen Wu; Bixiang Zhang; Yujuan Guan; Feng Li; Rongjuan Pei; Xinwen Chen
Journal:  J Virol       Date:  2022-06-07       Impact factor: 6.549

Review 6.  Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach.

Authors:  Jean-Michel Pawlotsky; Geoffrey Dusheiko; Angelos Hatzakis; Daryl Lau; George Lau; T Jake Liang; Stephen Locarnini; Paul Martin; Douglas D Richman; Fabien Zoulim
Journal:  Gastroenterology       Date:  2007-11-28       Impact factor: 22.682

7.  A study of hepatitis B virus reactivation associated with rituximab therapy in real-world clinical practice: a single-center experience.

Authors:  Myung Jin Oh; Heon Ju Lee
Journal:  Clin Mol Hepatol       Date:  2013-03-25

8.  Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma.

Authors:  Feng Wang; Rui-hua Xu; Hui-yan Luo; Dong-shen Zhang; Wen-qi Jiang; Hui-qiang Huang; Xiao-fei Sun; Zhong-jun Xia; Zhong-zhen Guan
Journal:  BMC Cancer       Date:  2008-04-23       Impact factor: 4.430
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.